Information on EC 2.4.1.19 - cyclomaltodextrin glucanotransferase

Word Map on EC 2.4.1.19
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Specify your search results
Select one or more organisms in this record:
Show additional data
Do not include text mining results
Include (text mining) results (more...)
Include results (AMENDA + additional results, but less precise; more...)


The expected taxonomic range for this enzyme is: Bacteria, Archaea, Eukaryota

EC NUMBER
COMMENTARY hide
2.4.1.19
-
RECOMMENDED NAME
GeneOntology No.
cyclomaltodextrin glucanotransferase
REACTION
REACTION DIAGRAM
COMMENTARY hide
ORGANISM
UNIPROT
LITERATURE
Cyclizes part of a (1->4)-alpha-D-glucan chain by formation of a (1->4)-alpha-D-glucosidic bond
show the reaction diagram
REACTION TYPE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
cyclization
-
-
-
-
hexosyl group transfer
hydrolysis
-
-
-
-
transglycosylation
-
-
-
-
PATHWAY
BRENDA Link
KEGG Link
MetaCyc Link
Starch and sucrose metabolism
-
-
starch degradation III
-
-
starch degradation IV
-
-
starch degradation
-
-
SYSTEMATIC NAME
IUBMB Comments
(1->4)-alpha-D-glucan:(1->4)-alpha-D-glucan 4-alpha-D-[(1->4)-alpha-D-glucano]-transferase (cyclizing)
Cyclomaltodextrins (Schardinger dextrins) of various sizes (6,7,8, etc. glucose units) are formed reversibly from starch and similar substrates. Will also disproportionate linear maltodextrins without cyclizing (cf. EC 2.4.1.25, 4-alpha-glucanotransferase).
CAS REGISTRY NUMBER
COMMENTARY hide
9030-09-5
-
ORGANISM
COMMENTARY hide
LITERATURE
UNIPROT
SEQUENCE DB
SOURCE
DSM8721
SwissProt
Manually annotated by BRENDA team
Bacillus autolyticus
11149
-
-
Manually annotated by BRENDA team
Bacillus autolyticus 11149
11149
-
-
Manually annotated by BRENDA team
NCIMB 13123
-
-
Manually annotated by BRENDA team
BIO-3m
-
-
Manually annotated by BRENDA team
strain 7364
-
-
Manually annotated by BRENDA team
strain E16
-
-
Manually annotated by BRENDA team
strain E16
-
-
Manually annotated by BRENDA team
BIO-13m
-
-
Manually annotated by BRENDA team
strain 290-3
-
-
Manually annotated by BRENDA team
strain 5119
-
-
Manually annotated by BRENDA team
strain 7b, isolated from Brazilian oat soil
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
strain 1018
SwissProt
Manually annotated by BRENDA team
Bacillus sp. 17. Jan
17-1
-
-
Manually annotated by BRENDA team
strain 17.1
SwissProt
Manually annotated by BRENDA team
strain 38.2
SwissProt
Manually annotated by BRENDA team
No. 5 strain
-
-
Manually annotated by BRENDA team
strain 6.6.3
SwissProt
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
AL-6
-
-
Manually annotated by BRENDA team
BE101
-
-
Manually annotated by BRENDA team
strain BL-12
-
-
Manually annotated by BRENDA team
G-825-6
-
-
Manually annotated by BRENDA team
Bacillus sp. Ha3-3-2/ATCC 39612
Ha3-3-2/ATCC 39612
-
-
Manually annotated by BRENDA team
Bacillus sp. INMIA 1919
INMIA 1919
-
-
Manually annotated by BRENDA team
Bacillus sp. INMIA A7/1
INMIA A7/1
-
-
Manually annotated by BRENDA team
Bacillus sp. INMIA T4
INMIA T4
-
-
Manually annotated by BRENDA team
Bacillus sp. INMIA t6
INMIA t6
-
-
Manually annotated by BRENDA team
IT25
-
-
Manually annotated by BRENDA team
NA-1
-
-
Manually annotated by BRENDA team
no. 9605
-
-
Manually annotated by BRENDA team
no. 9605
-
-
Manually annotated by BRENDA team
Carboxydocella sp.
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
human
-
-
Manually annotated by BRENDA team
strain M5a1
SwissProt
Manually annotated by BRENDA team
strain M5a1
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
-
-
-
Manually annotated by BRENDA team
strain 9229
SwissProt
Manually annotated by BRENDA team
strain 9229
SwissProt
Manually annotated by BRENDA team
strain NC22.13
-
-
Manually annotated by BRENDA team
strain ST-12 K
-
-
Manually annotated by BRENDA team
strain LMD24.10
SwissProt
Manually annotated by BRENDA team
DSM3638, gene pfcgt
UniProt
Manually annotated by BRENDA team
BIO-12H, BIO-13H
-
-
Manually annotated by BRENDA team
hog
-
-
Manually annotated by BRENDA team
Tac-3554
-
-
Manually annotated by BRENDA team
pv. citri
-
-
Manually annotated by BRENDA team
pv. campestris
-
-
Manually annotated by BRENDA team
GENERAL INFORMATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
physiological function
SUBSTRATE
PRODUCT                       
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
Reversibility
r=reversible
ir=irreversible
?=not specified
3-ketobutylidene-beta-2-chloro-4-nitrophenylmaltopentaoside + D-glucose
3-ketobutylidene-beta-2-chloro-4-nitrophenylmaltotetraoside + maltose
show the reaction diagram
3-ketobutylidene-beta-2-chloro-4-nitrophenylmaltopentaoside + maltose
3-ketobutylidene-beta-2-chloro-4-nitrophenylmaltotetraoside + maltotriose
show the reaction diagram
4,6-benzylidene-alpha-D-4-nitrophenylmaltoheptaose + D-glucose
4,6-benzylidene-maltopentaose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)2-D-glucose
show the reaction diagram
-
blocked p-nitrophenyl-(alpha-1,4-glucopyranosyl)6-D-glucose , weak cleavage
-
-
?
4,6-O-ethylidene-4-nitrophenyl-alpha-D-maltoheptaoside + maltose
?
show the reaction diagram
alpha-1,4-glucan + glycosyl acceptor
cyclodextrins
show the reaction diagram
alpha-1,4-glucan + glycosyl acceptor
cyclohexaamylose + cycloheptaamylose + cyclooctaamylose
show the reaction diagram
alpha-cyclodextrin + ascorbic acid
L-ascorbic acid-2-O-alpha-D-glucoside + L-ascorbic acid-2-O-alpha-D-oligoglucoside
show the reaction diagram
-
-
-
-
r
alpha-cyclodextrin + D-glucose
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
alpha-cyclodextrin + D-lactose
O-beta-D-galactopyranosyl-1,4-O-beta-D-glucopyranosyl alpha-D-glucopyranoside + glucose
show the reaction diagram
alpha-cyclodextrin + glycosyl acceptor
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
alpha-cyclodextrin + isoascorbic acid
L-isoascorbic acid-2-O-alpha-D-glucoside + L-isoascorbic acid-2-O-alpha-D-oligoglucoside
show the reaction diagram
-
-
-
-
r
alpha-cyclodextrin + maltohexaose
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
alpha-cyclodextrin + maltose
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
alpha-cyclodextrin + maltotetraose
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
alpha-cyclodextrin + maltotriose
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
alpha-cyclodextrin + sucrose
?
show the reaction diagram
-
ATCC 21783
-
-
r
alpha-cyclodextrin + sucrose
beta-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
amylopectin + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
-
alpha-cyclodextrin is preferentially produced. With a longer incubation period, the alpha-cyclodextrin to beta-cyclodextrin ratio declines
larger cyclodextrins (>8 glucose units) are formed in the initial reaction period
-
?
amylopectin + glycosyl acceptor
cycloheptaamylose + cyclohexaamylose + exo-branched cyclohexaamylose
show the reaction diagram
amylopectin beta-limit dextrin + glycosyl acceptor
?
show the reaction diagram
-
-
-
-
r
amylose
alpha-cyclodextrin
show the reaction diagram
amylose + glycosyl acceptor
?
show the reaction diagram
amylose + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
-
alpha-cyclodextrin is preferentially produced. With a longer incubation period, the alpha-cyclodextrin to beta-cyclodextrin ratio declines
larger cyclodextrins (>8 glucose units) are formed in the initial reaction period
-
?
amylose + glycosyl acceptor
cyclodextrin
show the reaction diagram
-
-
higher yield of large-ring cyclodextrins are ontained with a reaction temperature of 60°C compared to 40°C
-
?
beta-cyclodextrin + 4-nitrophenyl-beta-D-glucopyranose
?
show the reaction diagram
beta-cyclodextrin + D-glucose
?
show the reaction diagram
beta-cyclodextrin + D-glucose
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
beta-cyclodextrin + glycosyl acceptor
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
beta-cyclodextrin + maltohexaose
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
beta-cyclodextrin + maltose
?
show the reaction diagram
beta-cyclodextrin + maltose
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
beta-cyclodextrin + maltotetraose
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
beta-cyclodextrin + maltotriose
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
beta-cyclodextrin + salicin
?
show the reaction diagram
beta-cyclodextrin + sucrose
?
show the reaction diagram
-
ATCC 21783
-
-
r
beta-cyclodextrin + sucrose
alpha-cyclodextrin + maltooligosaccharide
show the reaction diagram
-
immobilized enzyme
-
r
corn starch + glycosyl acceptor
cyclodextrins
show the reaction diagram
-
-
beta-cyclodextrin is the major product
-
?
cycloamylose + D-glucose
?
show the reaction diagram
cycloamylose + salicin
?
show the reaction diagram
cyclodextrins + acceptor
linear maltooligosaccharide
show the reaction diagram
cycloheptaamylose + glycosyl acceptor
?
show the reaction diagram
-
-
-
-
r
cyclohexaamylose + D-glucose
linear oligosaccharide
show the reaction diagram
-
-
-
r
cyclohexaamylose + glycosyl acceptor
?
show the reaction diagram
-
-
-
-
r
cyclohexaamylose + maltose
linear oligosaccharide
show the reaction diagram
-
-
-
r
cyclohexaamylose + sucrose
linear oligosaccharide
show the reaction diagram
-
-
-
r
cyclomaltohexaose + cyclo-[alpha-D-Glcp-(1-3)-alpha-D-Glcp-(1-6)-alpha-D-Glcp-(1-3)-alpha-D-Glp-(1-6)]
cyclo-[alpha-D-Glcp-(1-3)-alpha-D-Glcp-(1-6)-alpha-D-Glcp-(1-3)-[alpha-D-Glcp-(1-4)]-alpha-D-Glp-(1-6)]
show the reaction diagram
-
-
-
-
?
cyclomaltohexaose + cyclo-[alpha-D-Glcp-(1-3)-alpha-D-Glcp-(1-6)-alpha-D-Glcp-(1-3)-alpha-D-Glp-(1-6)]
cyclo-[alpha-D-Glcp-(1-3)-[alpha-D-Glcp-(1-4)]-alpha-D-Glcp-(1-6)-alpha-D-Glcp-(1-3)-[alpha-D-Glcp-(1-4)]-alpha-D-Glp-(1-6)]
show the reaction diagram
-
-
-
-
?
cyclomaltohexaose + D-lactose
O-beta-D-galactopyranosyl-1,4-O-beta-D-glucopyranosyl alpha-D-glucopyranoside + maltooligosyl sugars
show the reaction diagram
cyclomaltohexaose + methyl alpha-D-glucopyranoside
maltodextrin glycoside
show the reaction diagram
-
the reactions are optimized by using different ratios of the D-glucopyranosides to cyclomaltohexaose. The lower ratios of 0.5-1.0 give a wide range of sizes from d.p. 2-17 and higher. As the molar ratio is increased from 1.0 to 3.0, the larger sizes, d.p. 9–17, decrease, and the small and intermediate sizes, d.p. 2–8, increase. As the molar ratios are increased further from 3.0 to 5.0, the large sizes completely disappear, the intermediate sizes, d.p. 4–8, decrease, and the small sizes, d.p. 2 and 3 become predominant
-
-
?
cyclomaltohexaose + methyl beta-D-glucopyranoside
maltodextrin glycoside
show the reaction diagram
-
the reactions are optimized by using different ratios of the D-glucopyranosides to cyclomaltohexaose. The lower ratios of 0.5-1.0 give a wide range of sizes from d.p. 2-17 and higher. As the molar ratio is increased from 1.0 to 3.0, the larger sizes, d.p. 9–17, decrease, and the small and intermediate sizes, d.p. 2–8, increase. As the molar ratios are increased further from 3.0 to 5.0, the large sizes completely disappear, the intermediate sizes, d.p. 4–8, decrease, and the small sizes, d.p. 2 and 3 become predominant
-
-
?
cyclomaltohexaose + phenyl alpha-D-glucopyranoside
maltodextrin glycoside
show the reaction diagram
-
the reactions are optimized by using different ratios of the D-glucopyranosides to cyclomaltohexaose. The lower ratios of 0.5–1.0 give a wide range of sizes from d.p. 2–17 and higher. As the molar ratio is increased from 1.0 to 3.0, the larger sizes, d.p. 9–17, decrease, and the small and intermediate sizes, d.p. 2–8, increase. As the molar ratios are increased further from 3.0 to 5.0, the large sizes completely disappear, the intermediate sizes, d.p. 4–8, decrease, and the small sizes, d.p. 2 and 3 become predominant
-
-
?
cyclomaltohexaose + phenyl beta-D-glucopyranoside
maltodextrin glycoside
show the reaction diagram
-
the reactions are optimized by using different ratios of the D-glucopyranosides to cyclomaltohexaose. The lower ratios of 0.5–1.0 give a wide range of sizes from d.p. 2–17 and higher. As the molar ratio is increased from 1.0 to 3.0, the larger sizes, d.p. 9–17, decrease, and the small and intermediate sizes, d.p. 2–8, increase. As the molar ratios are increased further from 3.0 to 5.0, the large sizes completely disappear, the intermediate sizes, d.p. 4–8, decrease, and the small sizes, d.p. 2 and 3 become predominant
-
-
?
dextrin
beta-cyclodextrin + alpha-cyclodextrin
show the reaction diagram
-
the maximum conversion of dextrin to beta-cyclodextrin and alpha-cyclodextrin is 29% both for the soluble and immobilized enzymes
-
-
?
dextrin + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
dextrin + glycosyl acceptor
cyclodextrins
show the reaction diagram
-
-
-
-
r
dodecyl-beta-D-maltoside + alpha-cyclodextrin
dodecyl-beta-D-maltooctaoside + ?
show the reaction diagram
gamma-cyclodextrin + glycosyl acceptor
maltooligosaccharide
show the reaction diagram
-
-
-
-
r
Glucidex 12 + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
-
E 192
-
r
Glucidex 2B + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
glycogen + acceptor
beta-cyclodextrin
show the reaction diagram
glycogen + H2O
cyclodextrins
show the reaction diagram
-
-
-
?
hydrolyzed cassava starch
beta-cyclodextrin
show the reaction diagram
hydrolyzed corn starch
beta-cyclodextrin
show the reaction diagram
hydrolyzed potato starch
beta-cyclodextrin
show the reaction diagram
L-ascorbic acid + beta-cyclodextrin
L-ascorbic acid-2-O-alpha-D-glucoside + ?
show the reaction diagram
-
-
-
?
L-ascorbic acid + maltodextrin
L-ascorbic acid-2-O-alpha-D-glucoside + ?
show the reaction diagram
-
-
-
?
L-ascorbic acid-(2-O-alpha-D-glucosyl)2 + glycosyl acceptor
Lascorbic acid alpha-D-glucoside + D-glucosyl-[glycosyl acceptor]
show the reaction diagram
-
-
-
r
L-ascorbic acid-(2-O-alpha-D-glucosyl)2 + H2O
L-ascorbic acid-2-O-alpha-D-glucoside + D-glucose
show the reaction diagram
-
-
-
r
L-ascorbic acid-(2-O-alpha-D-glucosyl)3 + glycosyl acceptor
L-ascorbic acid-(2-O-alpha-D-glucosyl)2 + D-glucosyl-[glycosyl acceptor]
show the reaction diagram
-
-
-
r
L-ascorbic acid-(2-O-alpha-D-glucosyl)3 + H2O
L-ascorbic acid-(2-O-alpha-D-glucosyl)2 + D-glucose
show the reaction diagram
-
-
-
r
L-ascorbic acid-(2-O-alpha-D-glucosyl)4 + glycosyl acceptor
L-ascorbic acid-(2-O-alpha-D-glucosyl)3 + glucosyl-[glycosyl acceptor]
show the reaction diagram
-
-
-
r
L-ascorbic acid-(2-O-alpha-D-glucosyl)4 + H2O
L-ascorbic acid-(2-O-alpha-D-glucosyl)3 + D-glucose
show the reaction diagram
-
-
-
r
L-ascorbic acid-2-O-alpha-D-glucoside + H2O
L-ascorbic acid + D-glucose
show the reaction diagram
-
-
-
?
linear maltooligosaccharide + acceptor
?
show the reaction diagram
maltodextrin
beta-cyclodextrin
show the reaction diagram
maltodextrin + glycosyl acceptor
beta-cyclodextrin + alpha-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
maltodextrin + glycosyl acceptor
cyclodextrins
show the reaction diagram
maltodextrin + L-ascorbic acid
2-O-D-glucopyranosyl-L-ascorbic acid + ?
show the reaction diagram
maltoheptaose + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
maltohexaose + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
-
E 192
-
r
maltohexaose + L-ascorbic acid
L-ascorbic acid-(2-O-alpha-D-glucosyl)6
show the reaction diagram
-
-
-
r
maltooligosaccharides + glycosyl acceptor
cyclodextrins
show the reaction diagram
maltopentaose + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
-
ATCC 21783
-
r
maltose + acceptor
?
show the reaction diagram
-
-
-
-
r
maltose + ascorbic acid
L-ascorbic acid-2-O-alpha-D-glucoside + D-glucose
show the reaction diagram
-
-
-
r
maltose + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
maltotetraose + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
maltotriose + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
maltotriose + maltotetraose
maltopentaose
show the reaction diagram
-
-
-
r
methyl-alpha-D-glucoside + glycosyl acceptor
cyclodextrins
show the reaction diagram
-
-
-
-
-
naringin + maltodextrin
?
show the reaction diagram
native starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
-
alpha-cyclodextrin is preferentially produced. With a longer incubation period, the alpha-cyclodextrin to beta-cyclodextrin ratio declines
larger cyclodextrins (>8 glucose units) are formed in the initial reaction period
-
?
p-nitrophenyl-(alpha-1,4-glucopyranosyl)2-D-glucose + glycosyl acceptor
p-nitrophenyl-D-glucose + p-nitrophenyl-alpha-1,4-glucopyranosyl-D-glucose + ?
show the reaction diagram
-
E 192
main product p-nitrophenyl-glucose when chain length of substrate is 4 glucose or less, p-nitrophenyl-alpha-1,4-glucopyranosyl-D-glucose when substrate chain length is 5 or more glucose residues
?
p-nitrophenyl-(alpha-1,4-glucopyranosyl)3-D-glucose + glycosyl acceptor
p-nitrophenyl alpha-D-glucoside + p-nitrophenyl-alpha-1,4-glucopyranosyl-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)2-D-glucose + ?
show the reaction diagram
-
E 192
product proportions 48:31:21
?
p-nitrophenyl-(alpha-1,4-glucopyranosyl)6-D-glucose + glycosyl acceptor
p-nitrophenyl-glucose + p-nitrophenyl-alpha-1,4-glucopyranosyl-D-glucose + p-nitrophenyl-(glucose)3 + p-nitrophenyl-(alpha-1,4-glucopyranosyl)3-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)4-D-glucose + ?
show the reaction diagram
-
E 192
product proportions 33:27:16:6:17
?
p-nitrophenyl-(alpha-1,4-glucopyranosyl)7-D-glucose + glycosyl acceptor
p-nitrophenyl-glucose + p-nitrophenyl-alpha-1,4-glucopyranosyl-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)2-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)3-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)4-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)5-D-glucose + ?
show the reaction diagram
-
E 192
product proportions 16:51:12:13:4:4
?
p-nitrophenyl-(glucose)5 + glycosyl acceptor
p-nitrophenyl alpha-D-glucoside + p-nitrophenyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside + p-nitrophenyl-(alpha-1,4-D-glucopyranosyl)2-D-glucose + p-nitrophenyl-(alpha-1,4-D-glucopyranosyl)3-D-glucose
show the reaction diagram
-
E 192
product proportions 32:50:12 6
?
p-nitrophenyl-(glucose)6 + glycosyl acceptor
p-nitrophenyl alpha-D-glucoside + p-nitrophenyl 4-O-alpha-D-glucopyranosyl-alpha-D-glucopyranoside + p-nitrophenyl-(alpha-1,4-glucopyranosyl)2-D-glucose + p-nitrophenyl-(alpha-1,4-glucopyranosyl)3-D-glucose + ?
show the reaction diagram
-
E 192
product proportions 18:53:21:8
?
Paselli starch
beta-cyclodextrin
show the reaction diagram
potato starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
potato starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
potato starch + glycosyl acceptor
gamma-cyclodextrin + beta-cyclodextrin
show the reaction diagram
raw corn starch
beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
raw starch
beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
rice starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
soluble potato starch
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble potoato starch
cyclodextrin
show the reaction diagram
soluble starch
alpha-cyclodextrin
show the reaction diagram
-
poly-lysine fused immobilization increases the Vmax of the immobilized CGTase by 40% without a change in Km. Maximum alpha-cyclodextrin productivity of 539.4 g/l*h is obtained with 2% soluble starch solution which is constantly fed at a flow rate of 4.0 ml/min in a continuous operation mode of a packed-bed reactor
-
-
?
soluble starch
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble starch
beta-cyclodextrin
show the reaction diagram
soluble starch + cellobiose
?
show the reaction diagram
-
-
-
-
r
soluble starch + D-fructose
?
show the reaction diagram
soluble starch + D-galactose
?
show the reaction diagram
soluble starch + D-glucose
cyclodextrins
show the reaction diagram
soluble starch + D-maltose
cyclodextrins
show the reaction diagram
soluble starch + D-rhamnose
?
show the reaction diagram
-
-
-
-
r
soluble starch + D-sorbose
?
show the reaction diagram
soluble starch + D-xylose
?
show the reaction diagram
soluble starch + glycosyl acceptor
alpha-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
alpha-cyclodextrin + beta cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
cyclodextrin
show the reaction diagram
-
-
-
-
?
soluble starch + glycosyl acceptor
cyclodextrins
show the reaction diagram
soluble starch + glycosyl acceptor
cycloheptaamylose
show the reaction diagram
soluble starch + glycosyl acceptor
cyclohexaamylose
show the reaction diagram
-
-
-
r
soluble starch + glycosyl acceptor
gamma-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
gamma-cyclodextrin + beta-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
maltose + maltotriose + maltotetraose + maltopentaose
show the reaction diagram
soluble starch + glycosyl acceptor
Schardinger beta-dextrin
show the reaction diagram
soluble starch + glycosyl acceptor
Schardinger dextrins
show the reaction diagram
soluble starch + H2O
cyclodextrins
show the reaction diagram
soluble starch + L-sorbose
?
show the reaction diagram
-
-
-
-
r
soluble starch + maltotriose
cyclodextrins
show the reaction diagram
soluble starch + myo-inositol
?
show the reaction diagram
-
-
-
-
r
soluble starch + ribose
?
show the reaction diagram
-
-
-
-
r
soluble starch + sucrose
?
show the reaction diagram
soluble starch + sucrose
maltosylfructose
show the reaction diagram
-
-
-
r
starch
alpha-cyclodextrin
show the reaction diagram
-
-
-
-
-
starch
beta-cyclodextrin
show the reaction diagram
starch
beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
starch
cyclodextrin
show the reaction diagram
starch
gamma-cyclodextrin
show the reaction diagram
starch + ascorbic acid
2-O-alpha-glucopyranosyl L-ascorbic acid
show the reaction diagram
-
-
-
-
r
starch + glycosyl acceptor
alpha-cyclodextrin
show the reaction diagram
-
-
-
-
?
starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
-
-
alpha-cyclodextrin, beta-cyclodextrin and gamma-cyclodextrin in the ratio of 0.26:1.0:0.86
-
?
starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
starch + glycosyl acceptor
cyclodextrin
show the reaction diagram
-
the cyclodextrin product specificity can be changed into linear product specificity, by introducing a five-residue insertion mutation at the donor substrate binding subsites. The CGTase mutants remain clearly different from the maltogenic alpha-amylase, as they have much lower hydrolytic activities, they form linear products of variable sizes and they retain a low cyclodextrin forming activity, whereas maltogenic alpha-amylases produce primarily maltose. The five-residue insertion, concomitantly, strongly enhances the exo-specificity of CGTase
-
-
?
starch + glycosyl acceptor
cyclodextrins
show the reaction diagram
starch + hesperidin
glycosyl hesperidin
show the reaction diagram
-
-
-
-
r
starch + maltose
beta-cyclodextrin + gamma-cyclodextrin + maltooligosaccharides
show the reaction diagram
starch + rutin
glycosyl rutin
show the reaction diagram
-
-
-
-
r
starch + salicin
glycosyl salicin
show the reaction diagram
-
-
-
-
r
starch + stevioside
glycosyl stevioside
show the reaction diagram
starch + sucrose
maltooligosyl sucrose
show the reaction diagram
stevioside + beta-cyclodextrin
4'-O-alpha-D-glycosyl stevioside + 4''-O-alpha-D-maltosyl stevioside + ?
show the reaction diagram
stevioside + maltodextrin
?
show the reaction diagram
stevioside + starch
?
show the reaction diagram
sweet potato starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
-
-
-
-
?
wheat starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
additional information
?
-
NATURAL SUBSTRATES
NATURAL PRODUCTS
REACTION DIAGRAM
ORGANISM
UNIPROT
COMMENTARY
(Substrate) hide
LITERATURE
(Substrate)
COMMENTARY
(Product) hide
LITERATURE
(Product)
REVERSIBILITY
r=reversible
ir=irreversible
?=not specified
potato starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
soluble starch + glycosyl acceptor
cyclodextrins
show the reaction diagram
soluble starch + glycosyl acceptor
Schardinger dextrins
show the reaction diagram
-
-
-
-
r
starch + glycosyl acceptor
alpha-cyclodextrin
show the reaction diagram
-
-
-
-
?
starch + glycosyl acceptor
beta-cyclodextrin
show the reaction diagram
starch + glycosyl acceptor
cyclodextrins
show the reaction diagram
wheat starch + glycosyl acceptor
alpha-cyclodextrin + beta-cyclodextrin + gamma-cyclodextrin
show the reaction diagram
additional information
?
-
METALS and IONS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
(NH4)6Mo7O24
-
5 mM, 115% of initial activity
BaCl2
-
relative activity 102.4%
CoCl2
activates at 4 mM
FeSO4
-
relative activity 107.6%
Hg2+
-
10 mM, complete inhibition
Li2SO4
-
relative activity 106%
MgSO4
-
relative activity 103.2%
Sr2+
-
activates
additional information
INHIBITORS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(+)-1-deoxynojirimycin
-
-
(NH4)6Mo7O24
-
-
1-deoxynojirimycin
2-mercaptoethanol
-
1 mM, 87% of initial activity
3-O-Methylglucose
-
E 192, 25% inhibition
acarbose
alpha-cyclodextrin
amygdalin
-
E 192, 75% inhibition
beta-cyclodextrin
Ca2+
-
about 90% residual activity at 1 mM
Cd2+
-
about 96% residual activity at 1 mM
cellobiose
-
E 192, 85% inhibition
CoCl2
-
1 mM, complete inhibition
CuSO4
-
1 mM, complete inhibition
Cyclodextrins
-
the enzyme activity is strongly inhibited by the reaction products
-
D-glucose
D-mannose
-
E 192, 20% inhibition
D-xylose
-
E 192, 3% inhibition
dithiothreitol
-
1 mM, 68% of initial activity
dodecyl-beta-D-maltoside
-
E 192, 55% inhibition
ethanol
FeCl3
-
1 mM, 70% inhibition
FeSO4
-
1 mM, complete inhibition
gamma-cyclodextrin
helicin
-
E 192, 88% inhibition
heptyl-thio-glucoside
-
E 192, 81% inhibition
HgCl2
K+
-
about 38% residual activity at 1 mM
K2SO4
-
1 mM, 54% inhibition
maltitol
-
E 192, 82% inhibition
maltose
methyl-alpha-D-glucoside
-
E 192, 80% inhibition
methyl-beta-glucoside
-
E 192, 76% inhibition
MgCl2
MgSO4
-
1 mM, 65% inhibition
NaCl
-
1 mM, 28% inhibition
NaNO3
-
1 mM, 54% inhibition
Ni2+
-
1 mM, 58% of initial activity
octyl-beta-D-glucoside
-
E 192, 46% inhibition
p-nitrophenyl-alpha-D-glucoside
-
E 192, 55% inhibition
p-nitrophenyl-beta-D-glucoside
-
E 192, 55% inhibition
palatinose
-
E 192, 68% inhibition
Salicin
Sn2+
-
slight
starch
Sucrose
-
E 192, 12% inhibition
Tetranitromethane
-
E 192
ZnCl2
ZnSO4
-
1 mM, complete inhibition
additional information
-
ACTIVATING COMPOUND
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
(CH3COO)2Pb
Bacillus autolyticus
-
relative activity 103%
2-mercaptoethanol
Bacillus autolyticus
-
relative activity 101%
Benzene
-
relative activity 106%
bromobenzene
Ca2+
-
4 mM, 22% activation
cyclohexadec-8-ene-1-one
Cyclohexane
cyclotridecanone
decane
-
increases the yield of cyclodextrin
Decanol
Dextrin
-
favores CGTase synthesis
dithiothreitol
Bacillus autolyticus
-
relative activity 101%
DTT
-
slight activation
ethanol
fructose
-
favores CGTase synthesis
galactose
-
favores CGTase synthesis
glucose
-
favores CGTase synthesis
Isopropanol
lactose
-
favores CGTase synthesis
light
-
illumination of the enzyme with white, linearly polarized light and at constant 25°C increases the enzyme activity producing a mixture of alpha-, beta-, and gamma-cyclodextrins. At a high enzyme concentration of 0.64 U/cm3, regardless the illumination time, formation of beta-cyclodextrin predominates. The highest yield of beta-cyclodextrin is afforded after 1 h illumination, but 2 h illumination leads to a significant increase in the yield of gamma-cyclodextrin
-
maltodextrin
-
favores CGTase synthesis
maltose
-
favores CGTase synthesis
mannitol
-
favores CGTase synthesis
n-butanol
NaCl
enzyme shows its maximum hydrolysis activity in a buffer with 1.5 M NaCl and retains up to 65% of its activity at 0.5 M NaCl
Octanol
p-chloromercuribenzoic acid
-
80 mM, relative activity 118%
PEG 3000
-
10% w/v, increases cyclodextrin production
pentadecane
phenylmethylsulfonyl fluoride
-
80 mM, relative activity 114%
sorbitol
starch
-
favores CGTase synthesis
Sucrose
-
favores CGTase synthesis
tert-butanol
-
strain 251, increases the yield of cyclodextrin
Toluene
Trichloroethylene
Triton X-100
Bacillus autolyticus
-
enhances specificity and yield of beta-cyclodextrin production
undecane
xylose
-
favores CGTase synthesis
additional information
-
synergistic promoting effects of glycine and Ca2+ on the extracellular secretion of the recombinant protein in Escherichia coli, optimal at 150 mM and 20 mM, respectively, overview
-
KM VALUE [mM]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.08 - 0.56
3-ketobutylidene-beta-2-chloro-4-nitrophenylmaltopentaoside
0.15 - 0.27
4,6-O-ethylidene-4-nitrophenyl alpha-D-maltoheptaoside
15.54
4-nitrophenyl-beta-D-glucopyranose
-
pH 8.5, 50°C
0.55 - 16
alpha-cyclodextrin
0.08 - 15.54
beta-cyclodextrin
1.69
cassava starch
-
pH 6.4, 55°C, formation of beta-cyclodextrin
-
0.1 - 0.88
gamma-cyclodextrin
7.3 - 160
glucose
38.3 - 51.7
L-ascorbic acid
0.47 - 1.65
maltodextrin
0.17 - 18.2
maltose
11.7 - 44
methyl-alpha-D-glucoside
1.1
soluble potato starch
-
pH 6.4, 55°C, formation of beta-cyclodextrin
-
0.043 - 15.54
soluble starch
-
0.0556 - 2.1
starch
additional information
additional information
-
TURNOVER NUMBER [1/s]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.122 - 15.5
3-ketobutylidene-beta-2-chloro-4-nitrophenylmaltopentaoside
558 - 1244
4,6-O-ethylidene-4-nitrophenyl alpha-D-maltoheptaoside
0.00183 - 0.0442
alpha-cyclodextrin
0.0095 - 0.014
beta-cyclodextrin
1612
cassava starch
Bacillus circulans
-
pH 6.4, 55°C, formation of beta-cyclodextrin
-
0.000086 - 0.000133
L-ascorbic acid
0.004 - 583
maltodextrin
558 - 1244
maltose
1.66
p-nitrophenyl-(alpha-1,4-glucopyranosyl)2-D-glucose
Bacillus circulans
-
E 192
0.833
p-nitrophenyl-(alpha-1,4-glucopyranosyl)3-D-glucose
Bacillus circulans
-
E 192
0.833
p-nitrophenyl-(alpha-1,4-glucopyranosyl)4-D-glucose, p-nitrophenyl-(alpha-1,4-glucopyranosyl)5-D-glucose, p-nitrophenyl-(alpha-1,4-glucopyranosyl)6-D-glucose
Bacillus circulans
-
E 192
-
0.25
p-nitrophenyl-(alpha-1,4-glucopyranosyl)7-D-glucose
Bacillus circulans
-
E 192
-
127.5 - 803
soluble potato starch
-
1.86 - 3.5
soluble starch
-
0.00267 - 329
starch
additional information
additional information
Paenibacillus macerans
-
-
-
kcat/KM VALUE [1/mMs-1]
SUBSTRATE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
950
cassava starch
Bacillus circulans
-
pH 6.4, 55°C, formation of beta-cyclodextrin
11851
730
soluble potato starch
Bacillus circulans
-
pH 6.4, 55°C, formation of beta-cyclodextrin
8845
additional information
additional information
Bacillus sp.
-
kcat/Km value for wild-type is 1.82 mg/ml, pH 6.0, 60°C
2
Ki VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
1.7
(+)-1-deoxynojirimycin
-
-
0.001
acarbose
-
-
65.4
D-glucose
-
-
13.7
maltose
-
-
3.4
Salicin
-
-
additional information
additional information
-
Ki-value for starch: 0.01 mg/ml (soluble enzyme), 0.0055 mg/ml (enzyme immobilized on alginate)
-
IC50 VALUE [mM]
INHIBITOR
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
IMAGE
0.0011 - 7.37
acarbose
SPECIFIC ACTIVITY [µmol/min/mg]
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
0.01
-
gamma-cyclodextrin, opening
0.02
-
beta-cyclodextrin, opening
0.21
-
crude enzyme, at pH 7.0 and 60°C
0.5
-
beta-cyclization
1.08
-
synthesis of alpha-cyclodextrin, 60°C, pH 6.0
1.1
-
gamma-cyclization, wild-type enzyme
1.24
-
gamma-cyclodextrin, opening
1.42
-
alpha-cyclodextrin, opening
1.7
-
beta-cyclodextrin, opening
2.4
-
maltotriose, disproportionation
9.7
-
purified native enzyme
14.4
-
beta-cyclodextrin-forming activity, recombinant wild-type enzyme
14.83
-
alpha-cyclodextrin, opening
15.5
-
maltotriose, disproportionation
21.7
-
beta-cyclodextrin-forming activity, recombinant mutant K47R
23
-
beta-cyclization
23.3
-
purified native enzyme, substrate is gelatinized soluble starch
23.5
-
coupling activity, purified enzyme
28
-
beta-cyclization
32.2
-
beta-cyclization, wild-type enzyme
32.26
-
commercial preparation
35.9
-
beta-cyclodextrin-forming activity, recombinant mutant K47H
37.4
-
alpha-cyclodextrin, coupling
45.9
-
alpha-cyclodextrin-forming activity, recombinant mutant K47L
46.4
-
alpha-cyclodextrin-forming activity, recombinant mutant K47S
47.4
-
alpha-cyclodextrin-forming activity, recombinant mutant K47T
51.4
-
beta-cyclodextrin-forming activity, recombinant mutant K47T
51.5
-
beta-cyclodextrin-forming activity, recombinant mutant K47S
52
-
beta-cyclization by strain BC8 enzyme
53.1
-
beta-cyclodextrin-forming activity, recombinant mutant K47L
57.7
-
after 274fold purification, at pH 7.0 and 60°C
60.39
-
purified enzyme
62.9
-
alpha-cyclodextrin-forming activity, recombinant mutant K47H
66.3
-
pH 9.0, 55°C
75.8
-
cyclization activity, purified enzyme
77.3
-
alpha-cyclodextrin-forming activity, recombinant mutant K47R
79.8
-
maltodextrin, pH 8.0, 50°C
85.1
-
alpha-cyclodextrin-forming activity, recombinant wild-type enzyme
88
-
E 192, dextrinizing-like activity
89.7
-
purified recombinant enzyme
90.3
-
hydrolyzed cassava starch, pH 8.0, 50°C
90.9
-
hydrolyzed potato starch, pH 8.0, 50°C
92.3
-
pH 8.0, 60°C
94
beta-cyclization, commercial preparation
97.1
-
hydrolyzed corn starch, pH 8.0, 50°C
127
-
beta-cyclization
142
-
mutant enzyme H59Q, cyclization activity
183.8
-
E 192, cyclodextrin synthesis
190.4
-
alpha-cyclization, wild-type enzyme
198.6
-
disproportionation activity, purified enzyme
203.1
-
alpha-cyclodextrin, coupling
205
-
purified enzyme
216
-
synthesis of beta-cyclodextrin, 60°C, pH 6.0
226
-
wild-type enzym, cyclization activity
265
-
beta-cyclization by strain BC251 enzyme
281
-
ATCC 21783
332
-
mutant enzyme Y96M, cyclization activity
342
-
mutant enzyme DELTA154-160, cyclization activity
347.9
-
purified enzyme, substrate maltodextrin
877.9
-
strain Al-6
883
-
starch, cyclodextrin synthesis
1650
-
ATCC 21783
2268
-
glycosyltransferase gene fused with thioredoxin, hexa-histidine and S-protein at the N-terminus and a proline-rich peptide at the C-terminus, pH 6.0, 40°C
4000
purified enzyme
5000
purified recombinant enzyme
6638
-
pH 6.0, 60°C
additional information
pH OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
4.5 - 4.7
4.5 - 5
-
ATCC 21783, crude enzyme, second pH optimum at 8.0-9.0
4.6
-
ATCC 21783 contains 3 isozymes, neutral, alkalic and acidic, possessing markedly different pH optima, 4.6, 7.0 and 9.5
5 - 6
Bacillus autolyticus
-
-
5 - 6
-
strain BIO-9m
5 - 6.5
-
strain B-4025
5 - 5.7
5 - 5.7
5 - 5.5
-
-
5.5 - 5.8
5.5 - 7
-
strain B-4018
5.5 - 8.5
-
-
5.9 - 6.5
-
the optimum pH for dextrinizing and cyclization activities of purified CGTases from both sources are similar around pH 6.5 and pH 5.9 respectively
6 - 6.5
-
strain BIO-13m
6 - 8
-
native enzyme
6.1 - 6.2
6.4
-
assay at
6.5 - 8.5
-
-
6.5 - 8
-
ATCC 39612/Ha3-3-2, cyclodextrin forming activity
6.5 - 7
-
strain BIO-13H
7 - 10
-
strain AL-6
7.5 - 8.5
-
var. alkalophilus ATCC 21783, second pH optimum at 4.5-4.7
7.5 - 10.5
-
strain AL-6, cyclodextrin forming
8 - 10
-
gamma-cyclodextrin production, reaction with 10% starch
8.6
two maxima at pH 6.0 and pH 8.6
9 - 11
-
strain dependent
9.5
-
ATCC 21783 contains 3 isozymes, neutral, alkalic and acidic, possessing markedly different pH optima, 4.6, 7.0 and 9.5
10.3
-
var. alkalophilus, ATCC 21783
additional information
-
the enzymes are more active in glycine/NaOH buffer compared with Na2HPO4/NaH2PO4 buffer at the same pH
pH RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
3.5 - 9.5
4 - 10
-
ATCC 21783
4 - 9
-
enzyme immobilized on glyoxyl-agarose and free enzyme present similar pH/activities profiles, with two peaks at pH values of 5.5 and 7 and a minimum at pH 6.0-6.5 in both amylolytic and CGTase activities. Activities decrease after these two maximum values. The glyoxyl CGTase retains 30% of amylase activity at pH 4 and 50% at pH 9. The soluble enzyme retains 10% and 30%, respectively. In synthetic activities differences are not significant
4 - 8.5
-
pH 4.0: about 65% of maximal activity, pH 8.5: about 65% of maximal activity, wild-type enzyme
4 - 11
-
activity range, about 60% of maximal activity at pH 4.5-9.0
4 - 8.5
4 - 9.5
-
loss of cyclization activity above and below
4.5 - 9.5
-
No. 5 strain
4.5 - 10
-
activity range, about 20% of maximal activity at pH 4.5, and 40% at pH 10.0
4.5 - 6.7
-
more than 80% activity in the range 5.0-6.7
5 - 10
5 - 11
-
-
5 - 8
-
more than 50% activity between pH 5.0 and 8.0
5 - 11
-
more than 80% of maximum activity
5 - 10
-
-
5 - 11
-
-
5 - 7
-
pH 5.0: about 25% of maximal activity, pH 7.0: about 60% of maximal activity, the enzyme does not show any activity at pH 4.0 and at pH 10.0
5 - 7
-
pH 5.0: about 70% of maximal activity, pH 9.0: about 70% of maximal activity, native enzyme
5 - 9
-
pH 5.0: about 50% of maximal activity, pH 9.0: about 55% of maximal activity, native enzyme
5 - 9.5
-
INMIA 3849
6 - 9
-
strain 1011, wild-type and mutant enzymes retain 80% activity
7 - 11
-
-
TEMPERATURE OPTIMUM
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
30 - 37
38
-
strain AL-6
40 - 50
-
native enzyme
40 - 60
45 - 50
45 - 55
-
-
50 - 55
60 - 62
-
INMIA 3849
60 - 65
60 - 70
-
cross-linked enzyme crystals
80 - 85
85
-
at pH 6.0, glutaraldehyde-activated chitosan spheres-immobilized enzyme
85 - 90
in presence of Ca2+
90
-
maximal cyclization activity of enzyme immobilized on glyoxyl-agarose, substrate: dextrin
90 - 100
-
cyclodextrin synthesis
95
purified enzyme
110
-
starch degrading
additional information
-
pT16 shows broader optimum temperatures for both dextrinizing and cyclization activities
TEMPERATURE RANGE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
10 - 80
-
-
20 - 75
-
activity range
20 - 70
-
-
20 - 60
-
about 65% activity at 20°C, around 95-100% activity at 30-50°C, about 50% activity at 60°C
30 - 70
30 - 85
-
-
30 - 65
-
No. 5 strain
30 - 70
35 - 70
-
ATCC 21783
35
50% of maximum activity
35 - 80
-
activity range, about 35% of maximal activity at 35°C and 80°C
40 - 50
-
more than 95% of maximum activity, recombinant enzyme
40 - 70
-
40°C: about 50% of maximal activity, 70°C: about 80% of maximal activity
40 - 75
-
40°C: about 40% of maximal activity, 75°C: about 15% of maximal activity, soluble enzyme
40 - 80
40 - 60
-
activity measurement at
40 - 90
-
immobilized enzyme
45 - 70
-
45°C: soluble enzyme shows about 50% of maximal activity, enzyme immobilized on glyoxyl-agarose shows about 60% of maximal activity, 70°C: soluble enzyme shows about 60% of maximal activity, enzyme immobilized on gyoxyl-agarose shows about 75% of maximal activity
50 - 70
50 - 90
50°C: about 45% of maximal activity, 90°C: about 35% of maximal activity
50 - 80
55 - 70
-
55°C: about 75% of maximal activity, 70°C: about 90% of maximal activity
55 - 80
-
55°C: about 60% of maximal activity, about 40% of maximal activity
60
-
76% of maximum activity
60
50% of maximum activity
60 - 100
-
60°C: about 55% of maximal activity, 100°C: about 50% of maximal activity, soluble enzyme and enzyme immobilized on glyoxyl-agarose, substrate: dextrin
80 - 120
-
-
pI VALUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
5.3
-
isoelectric focusing
SOURCE TISSUE
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
SOURCE
additional information
LOCALIZATION
ORGANISM
UNIPROT
COMMENTARY hide
GeneOntology No.
LITERATURE
SOURCE
additional information
PDB
SCOP
CATH
ORGANISM
UNIPROT
MOLECULAR WEIGHT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
33000
-
gel filtration Superose 6
33500
-
E 192, gel filtration superose 12 column
34000
-
gel filtration BioGel P-100
42000
-
INMIA 1919
44000
-
INMIA A7/1
48500
-
E 192, Fractogel TSK HW 55 S
56200
-
x * 56200, SDS-PAGE
56230
-
x * 56230, SDS-PAGE
58000
-
strain ATCC 21783, gel filtration
59000
-
x * 59000, SDS-PAGE
60000
Carboxydocella sp.
-
x * 60000, SDS-PAGE
65500
-
amino acid composition
68200
-
gel filtration
69000
-
x * 69000, SDS-PAGE
70500
-
ATCC 21783, SDS-PAGE
73400
-
1 * 73400, SDS-PAGE
74010
strain IFO3490, amino acid composition deduced from nucleotide sequence
74100
-
x * 74100, SDS-PAGE
74300
x * 74300, sequence calculation
74352
-
x * 74352, calculated from amino acid sequence
75140
x * 75140, calculated from sequence
75370
strain NO2, amino acid composition deduced from nucleotide sequence
76390
-
x * 76390, SDS-PAGE
79000
-
gel filtration
83000
-
SDS-PAGE
85000 - 88000
89000
-
gel filtration
90000
-
x * 90000, SDS-PAGE
103000
-
C31, gel filtration
139000
-
ATCC 8514, intracelluar enzyme
139300
-
sedimentation and diffusion data
145000
-
ATCC 8514, extracelluar enzyme
SUBUNITS
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
monomer
additional information
Crystallization/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
hanging-drop vapour-diffusion method at 293 K. X-ray diffraction data are collected to 2.2 A. The crystal belongs to space group R3, with unit-cell parameters a = b = 211.6, c = 52.7 A
-
hanging-drop vapour-diffusion method, crystal structure of native and acarbose-complexed mutant CGTase F283L and F283Y
-
strain 1011
-
crystals soaked with maltose
-
hanging drop vapor diffusion technique. Cross-linked enzyme crystals can be useful biocatalysts because they are stable at elevated temperature, in organic solvents, and in the presence of enzyme inactivation surfactant. They also maintain their activity against protein-digesting enzyme
-
mutant Y167H, hanging drop vapor diffusion method, using 15% (w/v) PEG 4000, 0.05 M Tris-HCl, 0.1 M sodium acetate buffer, 25 mM Na2HPO4, 150 mM NaCl, 10 mM imidazole pH 8.5
mutant Y195I, hanging drop vapor diffusion method, using 0.2 M sodium acetate trihydrate, 0.1 M Tris hydrochloride pH 9.0, 30% (w/v) polyethylene glycol 4000, at 22°C
-
purified recombinant mutant S77P CGTase in 10 mM sodium acetate, pH 5.5, large crystals from 17-20%-saturated ammonium sulfate at room temperature in 100 mM HEPES, pH 7.6, or 100 mM HEPES, pH 7.8, or 100 mM Tris/HCl, pH 8.0, like the wild-type enzyme, crystals are soaked in 25% v/v glycerol and directly flash-cooled, or soaked in 2% w/v acarbose, 4% w/v maltohexaose and 25% glycerol in 20% saturated ammonium sulfate for 25 min followed by flash-cooling, X-ray diffraction structure determination and analysis at 1.6 A resolution
-
pH STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
4 - 10
4.5 - 11
-
24 h, 25°C, stable
671395
5 - 11
-
stable within
719615
5 - 10
-
ATCC 21783
488826
5 - 11
75% of maximal activity within this range
684450
5 - 10.5
-
activity is not lost by incubation at 4°C for 1 month
488839
5 - 8
-
quite stable at 40°C for 3 h
488836
5
-
purified native enzyme, 50°C, 4 h, 34.2% retaining activity
702110
5.5 - 9
5.5 - 9.5
5.5 - 10
-
INMIA A/7
488855
5.5 - 11
-
strain 1011, wild-type and mutant enzyme, stable at 37°C for 30 min
488851
5.5 - 9
5.5
-
the half-life at pH 5.5 is 29.8 h
735493
5.5 - 8.5
-
highly stable
488861
6 - 10
6 - 9.5
6 - 10
6 - 10.5
-
stable
684523
6 - 10
-
stable
658790
6 - 11
-
HA3-3-2/ATCC 39612
488832
6 - 8
-
stable at 50°C
488839
6 - 7
-
purified native enzyme, 50°C, 4 h, almost completely stable
702110
6 - 11.5
-
purified enzyme, stable
684517
6 - 10
-
-
488864
6 - 9
-
the enzyme is stable from pH 6.0 to 9.0 for 30 min with a gradual loss of activity at higher and lower pH values in the range of 6.0-9.0
737302
6 - 9.5
-
-
719222
6 - 9
-
strain BIO-12H, highly stable
488861
6 - 9.5
-
strain BIO-13H, highly stable
488861
6.5 - 9.5
-
stable at 55°C
488839
6.5 - 8.5
-
stable at 50°C
488839
7 - 10
-
strain BA-4229, highly stable
488861
7 - 8
-
strain E 192, maximum stability, only 14% decrease in activity at pH 7.0
488842
7 - 11
-
-
488856
7 - 10
7 - 12
-
37°C, 30 min, stable
657629
7 - 9.2
-
stable at 50°C
488839
8 - 10
10 - 11
-
ATCC 21783, stability decreases by immobilization
488831
additional information
TEMPERATURE STABILITY
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
4 - 80
-
enzyme is stable from 4-45°C, still has 85% actvity after 30 min at 60°C, 40% activity after 30 min at 70°C, loses almost all activity after 30 min at 80°C
20 - 60
-
the enzyme remains fully stable between 20 and 40°C for 30 min, while at 50°C activity decreases to about 65% and is lost at 60°C
25
-
if submitted to strong stirring, promoting the apparition of gas bubbles and shear forces, the enzyme becomes inactivated at 25°C. This inactivation does not occur if the enzyme is immobilized on any porous support
30 - 65
-
Bacillus sp. strain 8SB synthesises a thermostable alkaline beta-CGTase, stability of the enzymes from diverse strains is strain-dependent, overview
35 - 65
-
purified native enzyme, 80% remaining activity at 35-65°C, pH 8.0, after 4 h, thermal deactivation above 70°C
40
-
stable for at least 1 h
40 - 60
-
strain E 192, heat labile, rapid inactivation at temperatures above 45, remaining activity is 75% after 20 min at 40°C, 10% at 50°C and only 5% after 1 min at 60°C, protected by substrate and Ca2+ enzyme is stable for at least 24 h at pH 6.0, very stable at pH 7.0, 48 h without any loss of activity
40 - 90
-
after 1 h of incubation, the enzyme shows about 43% activity at 40°C, about 80% at 50°C, about 90% at 55°C, 100% at 60°C, about 78% at 70°C, about 35% at 80°C, and about 20% activity at 90°C
40 - 50
-
immobilized enzyme is stable at 40°C, heat inactivation above 50°C
45 - 55
-
stable up to 45°C, 13.4% activity at 50°C, no activity above 55°C
45
-
half-life about 1.25 h
50 - 55
-
thermal stability of immobilized enzyme on chitosan increases from 50°C to 55°C
50 - 60
-
purified enzyme is quite stable at 50°C, but loses 80% of its activity at 60°C for 30 min
50 - 70
-
immobilized enzyme is more stable than soluble enzyme, inactivation of the soluble enzyme at 50°C is 1.6 times, at 60°C is 6.9 times and at 70°C is 24.3 times faster
58 - 60
60 - 80
-
the native enzyme shows a half-life of 93.45 min, 56.34 min, and 43.57 min at 60, 70, and 80°C, respectively
69
-
5 mM CaCl2 shifts the apparent melting point from 60°C to 69°C
70
purified enzyme, 30 min, 64% remaining activity
70 - 80
76
-
pH 6.0, 30 min, 50% loss of activity
80 - 110
85 - 100
extreme thermostability with addition of Ca2+, no loss of activity after 80 min at 85°C, half-life of 20 min at 100°C, recombinant enzyme half-life of 40 min at 100°C
90
purified enzyme, half-life is 85 min
90 - 100
-
extremely heat-stable, stable above 100°C in presence of starch
90
-
retains 100% cyclization activity after 2 h
95
purified enzyme, half-life is 46 min
100
purified enzyme, 20 min, 97% remaining activity
105
purified enzyme, 20 min, 60% remaining activity
additional information
GENERAL STABILITY
ORGANISM
UNIPROT
LITERATURE
ATCC 2178, exceptionally stable
-
Ca2+ stabilizes against thermal inactivation, 5 mM CaCl2 shifts the apparent melting point from 60°C to 69°C
-
Ca2+, 20 mM, increases thermal stability
-
cell membrane-immobilized purified enzyme retains, after 240 h repeated batch cultivation, 1.3-2.3fold increase of the CGTase yield compared to free cells at the end of the process, overview
-
cross-linked enzyme crystals are slightly more resistant to 2-butanol and acetonitrile than DMSO. In 15% solution of 2-butanol, over 100% of the activity is retained in CGTase-cross-linking enzyme crystals while 28% of the activity remains in the case of soluble CGTase
-
enzyme immobilized on alginate shows a high operational stability by retaining almost 75% of the initial activity after seventh use
-
enzyme stability is greatly enhanced with sorbitol
-
high substrate concentrations stabilize against thermal inactivation
-
immobilization in strongly hydrophilic microenvironment markedly enhances conformational stability in a wide temperature and pH range
-
more than 80% of the initial immobilized and crosslinked imprinted CGTase activity is retained for up to five cycles of synthesis reactions
not inactivated by 2 M guanidium chloride
-
prolonged digestion with trypsin does not affect the catalytic properties
-
relatively stable to Hg2+
-
SDS, 1%, only 7% of the activity of soluble enzyme activity remains, cross-linked enzyme crystals exhibit strong activity
-
the dextran (MW 47000)-conjugated form of the enzyme retains about 70.28% of the original specific catalytic activity exhibited by the native enzyme
-
the immobilized and CD8-crosslinked imprinted CGTase shows 15% higher stability in phosphate buffer containing up to 50% ethanol or cyclohexane compared to the native enzyme
-
the immobilized and CD8-crosslinked imprinted CGTase shows 30% higher stability in phosphate buffer containing up to 50% ethanol or cyclohexane compared to the native enzyme
-
the operational half-life of the packed-bed enzyme reactor (enzyme immobilized onto a cation exchanger by ionic interaction, poly-lysine fused immobilization) is estimated 12 days at 25°C and pH 6.0
-
the temperature stability of the immobilized and crosslinked imprinted CGTase at 60°C is considerably higher than that of the native enzyme
thermostability at 60°C and pH 7 reveals that the enzyme adsorbed on ionic supports is slightly less stable than the CNBr-agarose immobilized enzyme. The enzyme immobilized on Eupergit presents a very similar stability to this preparation while the glyoxyl-agarose is much more stable than any other preparation (by around a 15-fold factor) the glyoxyl-agarose immobilized enzyme is much more stable than any other preparation in presence of ethanol
-
ORGANIC SOLVENT
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
2-butanol
-
in 15% solution of 2-butanol, over 100% of the activity is retained in CGTase-cross-linking enzyme crystals while 28% of the activity remains in the case of soluble CGTase
2-propanol
acetonitrile
-
in 15% solution of 2-butanol, over 100% of the activity is retained in CGTase-cross-linking enzyme crystals while 60% of the activity remains in the case of soluble CGTase
benzene
chloroform
cyclohexane
decane
-
decane, nonane, stable in presence
diphenyl ether
-
diphenyl ether, 90% activity in presence
dodecane
-
stable in presence
Ethanol
hexane
Methanol
nonane
-
decane, nonane, stable in presence
octane
-
n-octane, 90% activity in presence
p-xylene
-
p-xylene, relative residual activity 100%
sodium dodecyl sulfate
-
not inactivated by 0.2%
toluene
urea
-
not inactivated by 8 M
STORAGE STABILITY
ORGANISM
UNIPROT
LITERATURE
-20°C, 0.05 M Tris-HCl, pH 7.0 or sodium acetate buffer, pH 6.5 for at least 6 months without loss of activity
-
4°C, pH 5.0-10.0, does not lose activity for 1 month
-
three-months storage of enzyme at 4°C and illuminated with white, linearly polarized light does not reduce the enhanced enzyme activity
-
Purification/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
; native enzyme 47fold by affinity chromatography
-
acetone precipitation, DEAE-cellulose column chromatography, and Sephadex G-100 gel filtration
-
ATCC 21783; ATCC 9995; C31
-
ATCC 39612/Ha3-3-2
-
beta-cyclodextrin affinity column chromatography
DF9, 2 different types, smooth and rough variation
-
from strain E16
-
from strain H69-3
-
from strain P4
-
from strain ST-12 K
-
from strains 7B, NCIM 5119 and no. 37
-
from strains BT01 and RB01
-
from the alkalophilic strain 20RF; from the alkalophilic strain 8SB; from the alkalophilic strains 8SB and 20RF
-
HisTrap column chromatography
-
HisTrap column chromatography, and gel filtration
Carboxydocella sp.
-
mutant Y167H with ammonium sulfate precipitation and Ni-NTA agarose column chromatography
native CGTase 22.9fold to homogeneity by hydrophobic interaction chromatography and starch adsorption
native enzyme 11.4fold from strain BL-12 by ultrafiltration and beta-cyclodextrin polymer affinity chromatography
-
native enzyme 13.7fold from strain ATCC 21783 by ultrafiltration and consecutive starch adsorption
native enzyme 315fold by ammonium sulfate fractionation, beta-cyclodextrin affinity chromatography, and ultrafiltration
-
native enzyme 99fold and recombinant enzyme 7fold from Escherichia coli both by starch adsorption, and hydrophobic interaction or beta-cyclodextrin affinity chromatography
-
native enzyme about 200fold from strain H69-3 by gel filtration, and one or two different steps of anion exchange chromatography
-
native enzyme by adsorption on starch, ion exchange chromatography, and gel filtration
-
native enzyme by starch adsorption and anion exchange chromatography
-
native extracellular enzyme 23.1fold from an alkalophilic strain by ultrafiltration and anion exchange chromatography to homogeneity
-
natural and recombinant enzyme
Ni-NTA agarose column chromatography
-
Ni-NTA agarose column chromatography and Sephacryl-100 gel filtration
-
Ni-NTA resin column chromatography
-
No. 5 strain
-
purification and concentration of CGTase by starch adsorption
-
rapid affinity purification
-
recombiant enzyme 25fold from Escherichia coli, by heat treatment at 60°C, hydrophobic interaction chromatography and starch adsorption, overview
recombinant
recombinant enzyme
recombinant enzyme from Escherichia coli strain BL21(DE3) inclusion bodies
-
recombinant enzyme from Escherichia coli strain DH5alpha
recombinant enzyme, cgtM gene product
recombinant enzymes, partially
-
recombinant fusion protein
-
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21 (DE3) by nickel affinity chromatography
-
recombinant His-tagged wild-type and mutant enzymes from Escherichia coli strain BL21(DE3) by nickel affinity chromatography
-
strain 1011, wild-type and mutants
-
wild-type and mutant enzymes
-
wild-type and recombinant enzymes
-
wild-type enzyme and mutant enzymes H59Q, Y96M, 90-PPI-92, and DELTA(154–160) expressed in Escherichia coli
-
Cloned/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
; cgtA gene cloned and expressed in Escherichia coli JM109
; gene sequencing of 16S rRNA
-
; strain IFO3490, vector plasmid pTB523, gene cgtM cloned in Bacillus subtilis NA-1, sequence determined, chimeric GTAse gene constructed by using cgt-1 from Bacillus stearothermophilus NO2
; strain NO2, vector plasmid pTB523, 3genes, cgt-1, cgt-5 and cgt-232 cloned in Bacillus subtilis NA-1, sequence determined, chimeric GTAse gene constructed by using cgt-1 and cgtM from Bacillus macerans IFO3490
ATCC21783 expressed in Bacillus subtilis; no. 38-2 cloned and sequenced; no. 8 cloned, sequenced and expressed in Escherichia coli
-
cloned and expressed in Escherichia coli
-
cloned and overexpressed in Bacillus subtilis
-
cloned and overexpressed in Escherichia coli
-
coexpression of folding accessory proteins for production of active cyclodextrin glycosyltransferase in Escherichia coli. The optimal coexpression partner, human peptidyl-prolyl cis-trans isomerase, is applied to fed-batch cultures of recombinant Escherichia coli in an attempt to develop an industrialy viable process
-
DNA and amino acid sequence determination and analysis, expression in Escherichia coli strain JM109
-
DNA and amino acid sequence determination and analysis, phylogenetic tree
expressed as inclusion body in recombinant Escherichia coli. The refolding yield of CGTase is enhanced by 71% by the immobilized poly-arginine fused minichaperone (MiniELR10) compared with a conventional refolding method. Minichaperone immobilized by poly-arginine fusion could assist refolding of heterologous proteins expressed as inclusion body
-
expressed in Bacillus subtilis strain WB600
-
expressed in Escherichia coli
expressed in Escherichia coli BL21(DE3) cells
expressed in in Bacillus subtilis strain WB600
-
expression in Bacillus subtilis KN2
-
expression in Escherichia coli
expression in Escherichia coli strain BL21(DE3), glycine, as a medium supplement, can enhance the extracellular secretion of recombinant alpha-CGTase by 11fold. Glycine supplementation exerts impaired cell growth inhibiting an increased enzyme production, but Ca2+ can remedy cell growth inhibition induced by glycine, thereby leading to further increase in the glycine-enhanced extracellular secretion of recombinant alpha-CGTase, effects on the bacterial cell membrane permeability, overview
-
expression in Saccharomyces cerevisiae strain EBY100, subcloning in Escherichia coli strain DH5 alpha
-
expression of cyclodextrin glycosyltransferase gene fused with thioredoxin, hexa-histidine and S-protein at the N-terminus and a proline-rich peptide at the C-terminus, in Escherichia coli
-
expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3)
-
expression of the enzyme in Escherichia coli strain DH5alpha
expression of wild-type and mutant enzymes in Bacillus subtilis strain DB104A
expression of wild-type and mutant enzymes in Bacillus subtilis strain DB104A, subcloning in Escherichia coli strain MC1061
-
gene cgt, expression in Escherichia coli strain JM109 and K12 N3406, enzyme secretion, batch fermentation method optimization via medium improvement, overview
-
gene cgtase, DNA and amino acid sequence determination and analysis, expression in Escherichia coli periplasmic fraction in different strains at low amounts, overview
gene cloned in Escherichia coli
-
gene coding for I transferred to a Bacillus host
-
gene pfcgt, DNA and amino acid sequence determination and analysis, phylogenetic analysis, expression in Escherichia coli
isolation of alkaliphilic Bacillus strains and determination of their phylogenetic and phenotypic characteristics, overview
-
M5a1 cloned and expressed
-
mutant enzyme Y93F is expressed in Escherichia coli BL21(DE3) cells
-
mutant enzymes H59Q, Y96M, 90-PPI-92, and DELTA(154–160) are constructed and produced using a recombinant Escherichia coli with a secretive expression system extracellularly
-
mutant Y167H is expressed in Escherichia coli BL21(DE3) cells
mutant Y195I is expressed in Escherichia coli BL21(DE3) cells
-
no. 38-2 cloned and sequenced; no. 8 cloned, sequenced and expressed in Escherichia coli
-
nucleotide sequence determined
overexpression and extracellular secretion of the recombinant alpha-cyclodextrin glycosyltransferase in Escherichia coli strain BL21(DE3), promotable by glycine, when supplemented optimally at the middle of the exponential growth phase at 1%, the enzyme production is increased by 11fold, glycine supplementation at the beginning of cell growth achieves a 1.2fold activation, overview. Glycine increases the cell membrane permeability, mechanism, overview
-
pET-8c vector, gene cloned and expressed in Escherichia coli BL21(DE3)
phylogenetic analysis
phylogenetic analysis, expression in Bacillus subtilis strain DB104A
-
phylogenetic analysis, expression in Bacillus subtilis strain NA-1
phylogenetic analysis, expression in Escherichia coli strain BL21(DE3)
phylogenetic analysis, expression of the enzyme from strain BC8 in Escherichia coli strain JM103, and of the enzyme from strain BC251 in Bacillus subtilis strain DB104A
-
phylogenetic tree
-
sp. 17-1, nucleotide sequence determined; sp. B1018, nucleotide sequence determined
-
strain 1011 cloned in Escherichia coli bacteriophage lambdaD69 and recloned in Escherichia coli plasmid pBR322
-
strain 1011 gene sequenced
-
strain NO2, mutant CGTases constructed from cgt1 gene and expressed in Bacillus subtilis NA-1
-
subcloned on pUB140, expressed in Bacillus subtilis LKS88
-
subcloning in Escherichia coli strain JM109, expression of His-tagged wild-type and mutant enzymes in Escherichia coli strain BL21(DE3)
-
the cyclodextrin glucanotransferase gene is cloned into plasmid pYD1, which allows regulated expression, secretion, and detection. The expression of CGTase with a-agglutinin at the N-terminal end on the extracellular surface of Saccharomyces cerevisiae is confirmed by immunofluorescence microscopy. This surface-anchored CGTase gives the yeast the ability to directly utilize starch as a sole carbon source and the ability to produce the anticipated products, cyclodextrins, as well as glucose and maltose. The resulting glucose and maltose, which are efficient acceptors in the CGTase coupling reaction, could be consumed by yeast fermentation and thus facilitated cyclodextrin production. On the other hand, ethanol produced by the yeast may form a complex with cyclodextrin and shift the equilibrium in favor of cyclodextrin production. The yeast with immobilized CGTase produces 24.07 mg/ml cyclodextrins when it is incubated in yeast medium supplemented with 4% starch
-
ENGINEERING
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
A230V
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
A315D
-
the mutation significantly changes the contribution of Ca2+ to the enzyme's thermostability
D577A
-
the mutation increases the beta-cyclization activity of the enzyme with 23% higher catalytic efficiency compared to the wild type. The mutation also increases the affinity for maltodextrin
D577E
-
the mutant displays an 11.2% increase in the beta-cyclization activity compared to the wild type enzyme
D577G
-
the mutation increases the beta-cyclization activity of the enzyme with 43.9% higher catalytic efficiency compared to the wild type. The mutation also increases the affinity for maltodextrin
D577H
-
the mutant displays a slight decrease in the beta-cyclization activity compared to the wild type enzyme
D577I
-
the mutation decreases the beta-cyclization activity of the enzyme
D577L
-
the mutation decreases the beta-cyclization activity of the enzyme
D577R
-
the mutant displays a 30.7% increase in the beta-cyclization activity compared to the wild type enzyme
D577V
-
the mutation decreases the beta-cyclization activity of the enzyme
F283L
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
H140Q
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
K192R
-
increase in half-life at 60°C from 9.7 min for the wild-type enzyme to 11.6 min for the mutant enzyme
K232E
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
K427S/V615L
reduction of cyclodextrin-forming activity
N188D
-
increase in half-life at 60°C from 9.7 min for the wild-type enzyme to 35 min for the mutant enzyme
N188D/K192R
-
increase in half-life at 60°C from 9.7 min for the wild-type enzyme to 56 min for the mutant enzyme
Q179G
-
mutation to residue G which is conserved in all the corresponding enzymes except in that from Bacillus circulans Df 9R. Activity and kinetic parameters remain unchanged
Q179L
-
mutation results in a different ratio of cyclodextrin products with a ratio for alpha- to beta- to gamma-cyclodextrin 1:1.7:0.7, a lower catalytic efficiency, and a decreased ability to convert starch into cyclodextrins
T185S
-
increase in half-life at 60°C from 9.7 min for the wild-type enzyme to 14.8 min for the mutant enzyme
T186Y
-
decrease in half-life at 60°C from 9.7 min for the wild-type enzyme to 8 min for the mutant enzyme
A230V
-
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
-
F283L
-
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
-
H140Q
-
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
-
K232E
-
the mutation confers increased resistance to inhibition by acarbose, the mutant shows highly increased IC50 compared to the wild-type enzyme
-
K427S/V615L
-
reduction of cyclodextrin-forming activity
-
Q179G
-
mutation to residue G which is conserved in all the corresponding enzymes except in that from Bacillus circulans Df 9R. Activity and kinetic parameters remain unchanged
-
Q179L
-
mutation results in a different ratio of cyclodextrin products with a ratio for alpha- to beta- to gamma-cyclodextrin 1:1.7:0.7, a lower catalytic efficiency, and a decreased ability to convert starch into cyclodextrins
-
D577A
-
the mutation increases the beta-cyclization activity of the enzyme with 23% higher catalytic efficiency compared to the wild type. The mutation also increases the affinity for maltodextrin
-
D577E
-
the mutant displays an 11.2% increase in the beta-cyclization activity compared to the wild type enzyme
-
D577G
-
the mutation increases the beta-cyclization activity of the enzyme with 43.9% higher catalytic efficiency compared to the wild type. The mutation also increases the affinity for maltodextrin
-
D577H
-
the mutant displays a slight decrease in the beta-cyclization activity compared to the wild type enzyme
-
D577I
-
the mutation decreases the beta-cyclization activity of the enzyme
-
D577K
-
the mutant displays a 1.5% increase in the beta-cyclization activity compared to the wild type enzyme
-
D577L
-
the mutation decreases the beta-cyclization activity of the enzyme
-
D577R
-
the mutant displays a 30.7% increase in the beta-cyclization activity compared to the wild type enzyme
-
D577V
-
the mutation decreases the beta-cyclization activity of the enzyme
-
A223H
-
mutant snzyme shows slight decreases in gamma-cyclodextrin-forming activity at pH 10.0, but shows 2fold increases at pH 7.5. pH activity profiles of the mutant shows higher activity at neutral pHs (pH 6-9) than that of the wild type CGTase
A223K
-
mutant enzyme shows slight decreases in gamma-cyclodextrin-forming activity at pH 10.0, but shows 3fold increases at pH 7.5. pH activity profiles of the mutant show higher activity at neutral pHs (pH 6-9) than that of the wild type CGTase
A223R
-
mutant enzyme shows a 4fold increase in gamma-cycodextrin-forming activity at pH 7.5 and 1.5fold increase in activity at pH 10.0. Mutant enzyme shows higher activity in pH range pH 6-10.5
A223H
-
mutant snzyme shows slight decreases in gamma-cyclodextrin-forming activity at pH 10.0, but shows 2fold increases at pH 7.5. pH activity profiles of the mutant shows higher activity at neutral pHs (pH 6-9) than that of the wild type CGTase
-
A223K
-
mutant enzyme shows slight decreases in gamma-cyclodextrin-forming activity at pH 10.0, but shows 3fold increases at pH 7.5. pH activity profiles of the mutant show higher activity at neutral pHs (pH 6-9) than that of the wild type CGTase
-
A223R
-
mutant enzyme shows a 4fold increase in gamma-cycodextrin-forming activity at pH 7.5 and 1.5fold increase in activity at pH 10.0. Mutant enzyme shows higher activity in pH range pH 6-10.5
-
DELTA154–160
-
mutation increases cyclization activity around 1.5times without any significant reduction of coupling and hydrolyzing activities, conversion yield into cyclodextrins is 39% higher than that of wild-type enzyme without any recognizable change in cyclodextrin ratio. pH-Stability decreases drastically in acidic pH region. Decrease in thermal stability
Y96M
-
mutation increases cyclization activity around 1.5times without any significant reduction of coupling and hydrolyzing activities, conversion yield into cyclodextrins is 28.6% higher than that of wild-type enzyme without any recognizable change in cyclodextrin ratio. Decrease in thermal stability
F183L
-
strain 1011, decreases affinity of acarbose
F259L
-
strain 1011, decreases affinity of acarbose
F283Y
-
mutation decreases the enzymatic activity in the basic pH range
H233Y
the mutant primarily produces maltoheptaose using beta-cyclodextrin via a hydrolysis reaction. The mutant enzyme also shows hydrolyzing activity against gamma-cyclodextrin but is unable to catalyze the hydrolysis of alpha-cyclodextrin
N132R
-
introduction of an ionic interaction at the first Ca2+ site, disruption of catalytic activity
N28R
-
introduction of an additional ionic interaction at the second Ca2+ site, mutant displays increased cyclization activity
S182E
-
mutation adjacent to the first Ca2+ site and the active site cleft. Mutant shows enhanced thermostability, and decreased catalytic activity
S182G
-
mutation adjacent to the first Ca2+ site and the active site cleft. Increase in half-life at 60°C to 94 min
Y195F
-
strain 1011
Y195I
-
the mutant produces less alpha-cyclodextrin, slightly more beta-cyclodextrin, and 3-4times more gamma-cyclodextrin than the wild type enzyme
Y195L
-
strain 1011; strain 1011, CGTase, in which Tyr-195 is replaced by a leucine residue, main initial product changed to gamma-cyclodextrin, absolute production being much larger than that of the wild-type
Y93F
-
the substitution causes no alpha-cyclodextrin formation, but produces 6% more beta-cyclodextrin, 16% less gamma-cyclodextrin, and decreases its kcat and kcat/Km values
F183L
-
strain 1011, decreases affinity of acarbose
-
F259L
-
strain 1011, decreases affinity of acarbose
-
F283L
-
starch degrading activity is similar to that of wild-type enzyme between the acidic and neutral pH ranges but decreases to 10% at pH 10.0. The pH-value of half-maximal activity at basic pH side is shifted to 8.6 from 10.0 of the wild-type. 23%-67% decrease in KM-value for 3-ketobutylidene-beta-2-chloro-4-nitrophenylmalto-pentaoside in the disproportionation reaction. The turnover-number for the disproportionating reaction at various pH conditions decreases to 1.6% to 4.4% compared with those of wild-type enzyme
-
F283Y
-
mutation decreases the enzymatic activity in the basic pH range
-
Y195F
-
strain 1011
-
Y195L
-
strain 1011; strain 1011, CGTase, in which Tyr-195 is replaced by a leucine residue, main initial product changed to gamma-cyclodextrin, absolute production being much larger than that of the wild-type
-
F183L
Bacillus sp. 17. Jan
-
strain 1011, decreases affinity of acarbose
-
F259L
Bacillus sp. 17. Jan
-
strain 1011, decreases affinity of acarbose
-
Y195F
Bacillus sp. 17. Jan
-
strain 1011
-
Y195L
Bacillus sp. 17. Jan
-
strain 1011; strain 1011, CGTase, in which Tyr-195 is replaced by a leucine residue, main initial product changed to gamma-cyclodextrin, absolute production being much larger than that of the wild-type
-
Y195I
-
the mutant produces less alpha-cyclodextrin, slightly more beta-cyclodextrin, and 3-4times more gamma-cyclodextrin than the wild type enzyme
-
Y93F
-
the substitution causes no alpha-cyclodextrin formation, but produces 6% more beta-cyclodextrin, 16% less gamma-cyclodextrin, and decreases its kcat and kcat/Km values
-
F183L
-
strain 1011, decreases affinity of acarbose
-
F259L
-
strain 1011, decreases affinity of acarbose
-
Y195F
-
strain 1011
-
Y195L
-
strain 1011; strain 1011, CGTase, in which Tyr-195 is replaced by a leucine residue, main initial product changed to gamma-cyclodextrin, absolute production being much larger than that of the wild-type
-
N132R
-
introduction of an ionic interaction at the first Ca2+ site, disruption of catalytic activity
-
N28R
-
introduction of an additional ionic interaction at the second Ca2+ site, mutant displays increased cyclization activity
-
S182E
-
mutation adjacent to the first Ca2+ site and the active site cleft. Mutant shows enhanced thermostability, and decreased catalytic activity
-
S182G
-
mutation adjacent to the first Ca2+ site and the active site cleft. Increase in half-life at 60°C to 94 min
-
F191Y
-
Phe at position 191 replaced by Tyr
F255I
-
cyclodextrins undetectable
D372K
-
site-directed mutagenesis, the mutant shows a great shift in substrate specificity towards the production of alpha-cyclodextrin
D372K/Y89R
-
site-directed mutagenesis, the mutant enzyme shows a 1.5fold increase in the production of alpha-cyclodextrin, with a concomitant 43% decrease in the production of beta-cyclodextrin compared to the wild-type CGTase
K47F
improved synthesis of 2-O-D-glucopyranosyl-L-ascorbic acid with maltodextrin as glucosyl donor, 30% increase in yield. Mutation leads to relatively lower cyclization activities and higher disproportionation activities. The enhancement of maltodextrin specificity may be due to the short residue chain and the removal of hydrogen bonding interactions between the side chain of residue 47 and the sugar at -3 subsite
K47H
-
site-directed mutagenesis, the mutant shows a shift in product specificity, slight enhancement of beta-cyclodextrin production and slight reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
K47R
-
site-directed mutagenesis, the mutant shows a shift in product specificity, slight enhancement of beta-cyclodextrin production and slight reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
K47S
-
site-directed mutagenesis, the mutant shows a shift in product specificity, enhancement of beta-cyclodextrin production and reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
K47T
-
site-directed mutagenesis, the mutant shows a shift in product specificity, enhancement of beta-cyclodextrin production and reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
K47V
improved synthesis of 2-O-D-glucopyranosyl-L-ascorbic acid with maltodextrin as glucosyl donor, 48% increase in yield. Mutation leads to relatively lower cyclization activities and higher disproportionation activities. The enhancement of maltodextrin specificity may be due to the short residue chain and the removal of hydrogen bonding interactions between the side chain of residue 47 and the sugar at -3 subsite
K47W
improved synthesis of 2-O-D-glucopyranosyl-L-ascorbic acid with maltodextrin as glucosyl donor, 24% increase in yield. Mutation leads to relatively lower cyclization activities and higher disproportionation activities. The enhancement of maltodextrin specificity may be due to the short residue chain and the removal of hydrogen bonding interactions between the side chain of residue 47 and the sugar at -3 subsite
Q265K
-
the mutant shows 15% cyclization (alpha-cyclodextrin-forming) and 236% hydrolysis (starch-degrading) activities compared to the wild type enzyme; the mutant with enhanced maltodextrin specificity produces higher 2-O-D-glucopyranosyl-L-ascorbic acid yields than the wild type enzyme. Compared with the wild type enzyme, the mutant has lower cyclization activity and higher hydrolysis and disproportionation activity
Q265K/Y195S
-
the mutant shows no cyclization (alpha-cyclodextrin-forming) and 226% hydrolysis (starch-degrading) activities compared to the wild type enzyme
R146A/D147P
-
the double mutant exhibits a ratio of alpha-cyclodextrin to total cyclodextrin production of 75.1%, approximately one-fifth greater than that of the wild-type enzyme (63.2%), without loss of thermostability
R146P/D147A
-
the double mutant exhibits a ratio of alpha-cyclodextrin to total cyclodextrin production of 76.1%, approximately one-fifth greater than that of the wild-type enzyme (63.2%), without loss of thermostability
Y195I
-
the mutation drastically alters the cyclodextrin specificity of the enzyme by switching toward the synthesis of both beta- and gamma-cyclodextrins
Y195S
-
the mutant shows no cyclization (alpha-cyclodextrin-forming) and 200% hydrolysis (starch-degrading) activities compared to the wild type enzyme; the mutant with enhanced maltodextrin specificity produces higher 2-O-D-glucopyranosyl-L-ascorbic acid yields than the wild type enzyme. Compared with the wild type enzyme, the mutant has lower cyclization activity and higher hydrolysis and disproportionation activity
Y195S/Q265K
-
compared with the wild type enzyme, the mutant has no cyclization activity and 498% hydrolysis and disproportionation activity
Y195S/Y260R
-
compared with the wild type enzyme, the mutant has lower cyclization activity and higher hydrolysis and disproportionation activity
Y260R
-
the mutant shows no cyclization (alpha-cyclodextrin-forming) and 226% hydrolysis (starch-degrading) activities compared to the wild type enzyme; the mutant with enhanced maltodextrin specificity produces higher 2-O-D-glucopyranosyl-L-ascorbic acid yields than the wild type enzyme. Compared with the wild type enzyme, the mutant has lower cyclization activity and higher hydrolysis and disproportionation activity
Y260R/Q265K
-
compared with the wild type enzyme, the mutant has 8% cyclization activity and 213% hydrolysis activity
Y260R/Q265K/Y195S
-
the mutant shows 12% cyclization (alpha-cyclodextrin-forming) and 557% hydrolysis (starch-degrading) activities compared to the wild type enzyme
Y260R/Y195S
-
the mutant shows no cyclization (alpha-cyclodextrin-forming) and 492% hydrolysis (starch-degrading) activities compared to the wild type enzyme
Y89D
-
site-directed mutagenesis, the mutant shows a shift in substrate specificity towards the production of alpha-cyclodextrin
Y89K
-
site-directed mutagenesis, the mutant shows a shift in substrate specificity towards the production of alpha-cyclodextrin
Y89N
-
site-directed mutagenesis, the mutant shows a shift in substrate specificity towards the production of alpha-cyclodextrin
Y89R
-
site-directed mutagenesis, the mutant shows a great shift in substrate specificity towards the production of alpha-cyclodextrin
Y167H
-
the mutant shows enhanced alpha-cyclodextrin specificity; the mutations increases the alpha:beta ratio in cyclodextrin product mixture from 3.4 to 7.8 in comparison with the wild type enzyme
-
Y195I
-
the mutation drastically alters the cyclodextrin specificity of the enzyme by switching toward the synthesis of both beta- and gamma-cyclodextrins
-
K47H
-
site-directed mutagenesis, the mutant shows a shift in product specificity, slight enhancement of beta-cyclodextrin production and slight reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
-
K47L
-
site-directed mutagenesis, the mutant shows a shift in product specificity, enhancement of beta-cyclodextrin production and reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
-
K47R
-
site-directed mutagenesis, the mutant shows a shift in product specificity, slight enhancement of beta-cyclodextrin production and slight reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
-
K47S
-
site-directed mutagenesis, the mutant shows a shift in product specificity, enhancement of beta-cyclodextrin production and reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
-
K47T
-
site-directed mutagenesis, the mutant shows a shift in product specificity, enhancement of beta-cyclodextrin production and reduction of alpha-cyclodextrin production compared to the wild-type enzyme, the mutant enzyme exhibits lower stability compared to the wild-type enzyme
-
Q265K
-
the mutant shows 15% cyclization (alpha-cyclodextrin-forming) and 236% hydrolysis (starch-degrading) activities compared to the wild type enzyme
-
Y195S
-
the mutant shows no cyclization (alpha-cyclodextrin-forming) and 200% hydrolysis (starch-degrading) activities compared to the wild type enzyme; the mutant with enhanced maltodextrin specificity produces higher 2-O-D-glucopyranosyl-L-ascorbic acid yields than the wild type enzyme. Compared with the wild type enzyme, the mutant has lower cyclization activity and higher hydrolysis and disproportionation activity
-
Y260R
-
the mutant shows no cyclization (alpha-cyclodextrin-forming) and 226% hydrolysis (starch-degrading) activities compared to the wild type enzyme; the mutant with enhanced maltodextrin specificity produces higher 2-O-D-glucopyranosyl-L-ascorbic acid yields than the wild type enzyme. Compared with the wild type enzyme, the mutant has lower cyclization activity and higher hydrolysis and disproportionation activity
-
synthesis
-
immobilization of enzyme on mesoporous silica microspheres produces high yields of immobilization, up to 83%, and activity recoveries, up to 73%. The soluble enzyme and its immobilized form show similar values for the optimal pH activity, while optimal reaction temperatures are 100°C and 80°C, respectively. The immobilized enzyme shows similar values for Km and thermal stabilities as the soluble form, while its Vmax is lower. The immobilized enzyme was tested in repeated batches in order to simulate recovery and reuse, keeping about 60% of the initial catalytic activity after 15 cycles
S77P
-
site-directed mutagenesis, mutant kinetics compared to the wild-type enzyme, molecular modelling of the location and effect of S77P mutation on the Tabium CGTase active-site conformation
W239L
-
site-directed mutagenesis, mutant kinetics compared to the wild-type enzyme, the mutation destroys a hydrogen-bonding interaction between the side chains of Asp209 and Trp239, compromising the stability of the mutant
W239R
-
site-directed mutagenesis, mutant kinetics compared to the wild-type enzyme, the mutation destroys a hydrogen-bonding interaction between the side chains of Asp209 and Trp239, compromising the stability of the mutant
S77P
-
site-directed mutagenesis, mutant kinetics compared to the wild-type enzyme, molecular modelling of the location and effect of S77P mutation on the Tabium CGTase active-site conformation
-
W239L
-
site-directed mutagenesis, mutant kinetics compared to the wild-type enzyme, the mutation destroys a hydrogen-bonding interaction between the side chains of Asp209 and Trp239, compromising the stability of the mutant
-
W239R
-
site-directed mutagenesis, mutant kinetics compared to the wild-type enzyme, the mutation destroys a hydrogen-bonding interaction between the side chains of Asp209 and Trp239, compromising the stability of the mutant
-
additional information
Renatured/COMMENTARY
ORGANISM
UNIPROT
LITERATURE
recombinant CGTase from inclusion bodies by solubilization in 6 M urea, refolded by dialysis and heated to 80°C for 20 min
-
APPLICATION
ORGANISM
UNIPROT
COMMENTARY hide
LITERATURE
agriculture
food industry
industry
nutrition
pharmacology
synthesis
Show AA Sequence (137 entries)
Please use the Sequence Search for a specific query.